Clinical Trial Update: A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating the effects on sleep and safety of RE03 in PTSD patients with sleep disturbances; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Posttraumatic Stress Disorder

Drugs mentioned

• RE03

Snippet

Sponsor: Reconnect Labs | Conditions: Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia | Phase 2 | Status: RECRUITING